while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.
. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
.
.
.
.